NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 09-30. Amounts in USD.

Revenue Quarterly

0 1.5M 3M 4.5M Q2 '13: 406 Q3 '13: 451 Q4 '13: 252 Q1 '14: 140 Q2 '14: 165 Q3 '14: 303 Q4 '14: 139 Q1 '15: 166 Q2 '15: 113 Q3 '15: 0 Q4 '15: 0 Q2 '16: 0 Q3 '16: 0 Q4 '16: 0 Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q1 '21: 71.5K Q2 '21: 18.2K Q3 '21: 40.1K Q4 '21: 48.3K Q1 '22: 33.7K Q2 '22: 36.6K Q3 '22: 32K Q4 '22: 68.8K Q1 '23: 114.6K Q2 '23: 466.2K Q3 '23: 629.9K Q4 '23: 741.8K Q1 '24: 977.6K Q2 '24: 1.4M Q3 '24: 825.8K Q4 '24: 272.3K Q1 '25: 3.3M Q2 '25: 1.4M Q3 '25: 1.7M Q4 '25: 2.7M Q1 '26: 2.9M Q2 '26: 1.9M Q3 '26: 2M Q2 '14 Q3 '15 Q1 '17 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Gross Profit Quarterly

-700K 0 700K 1.4M 2.1M Q2 '11: 3.1K Q3 '11: 1.2K Q4 '11: 812 Q2 '12: 147 Q3 '12: 391 Q4 '12: 23 Q1 '13: 360 Q2 '13: 406 Q3 '13: 451 Q4 '13: 252 Q1 '14: 140 Q2 '14: 165 Q3 '14: 303 Q4 '14: 139 Q1 '21: -37.7K Q2 '21: -21.1K Q3 '21: -21.8K Q4 '21: -17.1K Q1 '22: -13.1K Q2 '22: -36.2K Q3 '22: -6.4K Q4 '22: -15.1K Q1 '23: -12.3K Q2 '23: 31.5K Q3 '23: 243.7K Q4 '23: 193.7K Q1 '24: 266.3K Q2 '24: 390.4K Q3 '24: 281.9K Q4 '24: 141.1K Q1 '25: 1.9M Q2 '25: 771.1K Q3 '25: 914.8K Q4 '25: 1.5M Q1 '26: 1.6M Q2 '26: 990.3K Q3 '26: 1.2M Q3 '11 Q1 '13 Q2 '14 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Operating Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q4 '16: -8.6K Q1 '17: -65.7K Q2 '17: -516.1K Q3 '17: -888.7K Q4 '17: -893.8K Q1 '18: -773.8K Q2 '18: -1.1M Q3 '18: -1.2M Q4 '18: -1.1M Q1 '19: -1.1M Q2 '19: -1.5M Q3 '19: -1.9M Q4 '19: -1.4M Q1 '20: -1.8M Q2 '20: -1.4M Q3 '20: -1.6M Q4 '20: -117.4K Q1 '21: -2.1M Q2 '21: -2.4M Q3 '21: -3M Q4 '21: -2.6M Q1 '22: -2.8M Q2 '22: -3.1M Q3 '22: -2.8M Q4 '22: -1.4M Q1 '23: -1.8M Q2 '23: -3.5M Q3 '23: -3.5M Q4 '23: -3.2M Q1 '24: -3.4M Q2 '24: -2.9M Q3 '24: -2.8M Q4 '24: -2.8M Q1 '25: 1.7M Q2 '25: -2.7M Q3 '25: -1.9M Q4 '25: -1.4M Q1 '26: -1.7M Q2 '26: -2.4M Q3 '26: -2.4M Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Net Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q4 '16: -12.2K Q1 '17: -91.5K Q2 '17: -729.6K Q3 '17: -1.3M Q4 '17: -1.4M Q1 '18: -1.6M Q2 '18: -1.4M Q3 '18: -1.3M Q4 '18: -2.5M Q1 '19: -1.4M Q2 '19: -2.2M Q3 '19: -1.9M Q4 '19: -1.4M Q1 '20: -4.6M Q2 '20: -1.3M Q3 '20: -7.1M Q4 '20: -566.4K Q1 '21: -2M Q2 '21: -2.4M Q3 '21: -3M Q4 '21: -2.6M Q1 '22: -2.8M Q2 '22: -3.1M Q3 '22: -2.8M Q4 '22: -1.4M Q1 '23: -1.7M Q2 '23: -3.5M Q3 '23: -3.5M Q4 '23: -3.1M Q1 '24: -3.3M Q2 '24: -2.9M Q3 '24: -2.8M Q4 '24: -3.4M Q1 '25: 1.8M Q2 '25: -2.3M Q3 '25: -1.5M Q4 '25: -1.6M Q1 '26: -1.4M Q2 '26: -2.4M Q3 '26: -2M Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Cost of Revenue Quarterly

0 500K 1M 1.5M Q2 '12: 0 Q3 '12: 0 Q4 '12: 0 Q2 '14: 0 Q3 '14: 0 Q4 '14: 0 Q1 '21: 109.1K Q2 '21: 39.4K Q3 '21: 61.9K Q4 '21: 65.5K Q1 '22: 46.8K Q2 '22: 72.8K Q3 '22: 38.5K Q4 '22: 83.8K Q1 '23: 126.9K Q2 '23: 434.7K Q3 '23: 386.2K Q4 '23: 548.1K Q1 '24: 711.3K Q2 '24: 986.9K Q3 '24: 543.9K Q4 '24: 131.2K Q1 '25: 1.3M Q2 '25: 615.5K Q3 '25: 781.2K Q4 '25: 1.2M Q1 '26: 1.3M Q2 '26: 871.8K Q3 '26: 790.5K Q2 '12 Q3 '14 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q4 '16: -5.6K Q1 '17: -7.3K Q2 '17: -350.9K Q3 '17: -562.2K Q4 '17: -596.5K Q1 '18: -598.4K Q2 '18: -591.3K Q3 '18: -703.6K Q4 '18: -934.3K Q1 '19: -699.7K Q2 '19: -1.9M Q3 '19: -1.7M Q4 '19: -1.1M Q1 '20: -1.2M Q2 '20: -1.3M Q3 '20: -1.2M Q4 '20: 272.7K Q1 '21: -1.9M Q2 '21: -2.4M Q3 '21: -2.3M Q4 '21: -2M Q1 '22: -2.7M Q2 '22: -3.2M Q3 '22: -2.6M Q4 '22: 1M Q1 '23: -3.5M Q2 '23: -3.6M Q3 '23: -2.9M Q4 '23: -2.9M Q1 '24: -3.8M Q2 '24: -2.2M Q3 '24: -2.4M Q4 '24: -2.7M Q1 '25: 208K Q2 '25: -56.1K Q3 '25: -1.5M Q4 '25: -1.5M Q1 '26: -3.1M Q2 '26: -1.3M Q3 '26: -1.1M Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Free Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '19: -1.7M Q1 '20: -1.2M Q2 '20: -1.3M Q3 '20: -1.2M Q4 '20: 216.3K Q3 '21: -2.3M Q4 '21: -2.1M Q1 '22: -2.7M Q2 '22: -3.3M Q3 '22: -2.7M Q4 '22: 951.6K Q1 '23: -3.5M Q2 '23: -3.7M Q3 '23: -3.1M Q4 '23: -3M Q1 '24: -3.8M Q2 '24: -2.2M Q3 '24: -2.4M Q4 '24: -2.7M Q1 '25: 183.6K Q2 '25: -59.3K Q3 '25: -1.5M Q4 '25: -1.5M Q1 '26: -3.2M Q2 '26: -1.4M Q3 '26: -1.1M Q1 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q3 '10: 4.2M Q4 '10: 4.5M Q2 '11: 4.5M Q3 '11: 4.5M Q4 '11: 4.6M Q2 '12: 5.1M Q3 '12: 4.5M Q4 '12: 4.5M Q2 '13: 5.1M Q3 '13: 4.5M Q4 '13: 4.5M Q2 '21: 11.2M Q3 '21: 12M Q1 '22: 15.4M Q2 '22: 16.2M Q3 '22: 16.2M Q1 '23: 16.2M Q2 '23: 16.4M Q3 '23: 17.6M Q1 '24: 24M Q2 '24: 25.9M Q3 '24: 27.4M Q1 '25: 30.9M Q2 '25: 5.2M Q3 '25: 8.1M Q1 '26: 50.3M Q2 '26: 8.5M Q3 '26: 8.7M Q3 '11 Q4 '12 Q2 '21 Q3 '22 Q1 '24 Q2 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.70 -1.80 -0.90 0.00 0.90 1.80 2.70 Q4 '15: 0.00 Q1 '16: 0.00 Q2 '16: 0.00 Q3 '16: 0.00 Q4 '16: -0.01 Q1 '18: -0.75 Q2 '18: -0.78 Q3 '18: -0.72 Q4 '18: -0.82 Q1 '19: -0.75 Q2 '19: -0.78 Q3 '19: -0.76 Q4 '19: -0.57 Q1 '20: -0.77 Q2 '20: -0.86 Q3 '20: -2.05 Q4 '20: -2.52 Q1 '21: -2.44 Q2 '21: -2.36 Q3 '21: -1.28 Q4 '21: -0.94 Q1 '22: -0.86 Q2 '22: -0.84 Q3 '22: -0.76 Q4 '22: -0.63 Q1 '23: -0.56 Q2 '23: -0.58 Q3 '23: -0.61 Q4 '23: -0.65 Q1 '24: -0.68 Q2 '24: -0.58 Q3 '24: -0.48 Q4 '24: -0.46 Q1 '25: -0.26 Q2 '25: -0.59 Q3 '25: -0.68 Q4 '25: -0.09 Q1 '26: -0.18 Q2 '26: -0.02 Q3 '26: -0.11 Q4 '16 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.